Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.08 USD | +5.74% | +6.45% | +91.34% |
05-14 | Stephens Starts Inovio Pharmaceuticals With Overweight Rating, $20 Price Target | MT |
05-13 | Transcript : Inovio Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+91.34% | 296M | |
+27.28% | 49.18B | |
+0.63% | 42.11B | |
+50.13% | 40.37B | |
-5.26% | 28.85B | |
+12.38% | 26.09B | |
-21.92% | 18.71B | |
+9.29% | 13.26B | |
+31.00% | 12.32B | |
-0.39% | 11.99B |
- Stock Market
- Equities
- INO Stock
- News Inovio Pharmaceuticals, Inc.
- Transcript : Inovio Pharmaceuticals, Inc. - Shareholder/Analyst Call